The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Share News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 488.10
Bid: 489.10
Ask: 489.20
Change: 5.20 (1.08%)
Spread: 0.10 (0.02%)
Open: 477.10
High: 490.20
Low: 475.40
Prev. Close: 482.90
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Aviva hikes dividend after robust first half

Wed, 16th Aug 2023 07:44

(Sharecast News) - Global insurance giant Aviva reported robust first-half growth on Wednesday, with operating profit rising 8% year-on-year to £715m.

The FTSE 100 company's Solvency II own funds generation jumped 26% to £648m, while the Solvency II shareholder cover ratio dipped 10 percentage points to stand at 202%.

Gross written premiums in general insurance rose 12%, reaching £5.27bn, as the firm's undiscounted combined operating ratio slightly increased by one percentage point to 94.8%.

In insurance, wealth and retirement, Aviva said the value of new business in the sector grew 7% to £319m, while the operating value added saw a substantial jump of 32% to £640m.

The company's IFRS profit for the period swung to £377m, from a loss of £198m in the first six months of 2022.

Cash remittances increased 3% to £825m, while Aviva's centre liquidity saw a reduction of 28%, settling at £1.6bn.

The board hiked the interim dividend per share by 8% to 11.1p, after Aviva executed a £300m buyback in the first half.

Looking ahead, Aviva said it remained confident over its future performance, underpinned by the strong first half.

In general insurance, it said its focus remained on apt pricing strategies amid an inflationary environment.

Aviva said it expected the rating environment to stay favourable, and anticipated benefits from rating actions to be implemented in the second half.

In insurance, wealth and retirement, the company also forecast continued growth.

The firm said it was optimistic about momentum in bulk purchase annuities (BPAs), as more pension schemes looked to mitigate risks.

Despite near-term challenges in the Adviser Platform, the company said it saw significant growth prospects in the Workplace business segment and strong demand for Protection and Health products.

Aviva projected full-year 2023 group operating profit to increase by between 5% and 7% from the £1.35bn it recorded in 2022.

Additionally, it said it was on course to surpass its target of £1.5bn per annum for Solvency II operating own funds generation by 2024, and was also aiming to achieve its £750m gross cost reduction target a year ahead of schedule.

Aviva said it anticipated a dividend payment of around £915m, or 33.4p, for 2023.

"Aviva is delivering consistently strong and profitable growth - in the first half of 2023 we grew sales, operating profit and dividends for our shareholders," said group chief executive officer Amanda Blanc.

"Our excellent trading momentum is a direct result of the decisions we have taken over the last three years to re-focus Aviva.

"Today, Aviva has leading positions in growing markets, providing strong resilience in the current economic climate."

Blanc said that in the UK and Ireland, general insurance premiums were up 13%, with healthy sales in both our commercial and personal lines businesses, where its Aviva Zero product had now attracted 250,000 new policies since launch.

"In wealth, our market-leading Workplace business grew net flows by 25%.

"We continue to see very strong demand for private health insurance, with sales increasing by 58% as we expanded our services to corporate and individual customers.

"Our excellent Canadian general insurance business is also growing well, with sales 12% higher as a result of a strong performance in commercial lines, and the continued success of our local banking partnership."

Amanda Blanc described Aviva's cash and capital position as "robust", adding that in line with guidance, it had increased its interim dividend by 8% to 11.1p, and estimated full-year 2023 operating profit growth of between 5% and 7%.

"We expect to make further strong progress with our clear strategy, growth opportunities in all of our markets, and the £1bn investment well underway to accelerate our future performance.

"Aviva's performance and prospects have been transformed from just a few years ago - today's Aviva is about delivery and momentum, and these results show that Aviva is consistently meeting its promises.

"We expect to exceed our financial targets and we are making progress each quarter, as we said we would."

Reporting by Josh White for Sharecast.com.

More News
21 Sep 2023 12:52

IN BRIEF: Watchstone interim loss widens on costs of claim against PwC

Watchstone Group PLC - former insurance software provider originally called Quindell; now cash shell pursuing litigation claims - Pretax loss widens to GBP6.0 million in six months that ended June 30 from GBP2.1 million a year before. Has no revenue, so loss is due to higher administrative expenses. These primarily are legal costs, including GBP4.9 million for Watchstone's claim against PricewaterhouseCoopers LLP. The High Court dismissed Watchstone's claim, and while it seeks permission to appeal, Watchstone must pay PwC's legal costs, as well as its own. Other outstanding claims are against Aviva Canada, part of Aviva PLC, and against UK tax collector HMRC over the recovery of historic VAT. "We remain focussed on realising the group's remaining litigation assets as efficiently as possible and are confident of returning further cash sums to shareholders in due course," Watchstone says.

Read more
13 Sep 2023 17:01

LONDON MARKET CLOSE: FTSE 100 tips into red as UK economy shrinks

(Alliance News) - The FTSE 100 dipped into the red at the close on Wednesday, weighed down by news that the UK economy shrank more than expected in July, just one week before the Bank of England's next interest rate decision.

Read more
13 Sep 2023 11:49

LONDON MARKET MIDDAY: Stocks down as investors wait for US inflation

(Alliance News) - Stock prices in London were lower at midday Wednesday as investors eyed a key US inflation reading later in the day, ahead of the Federal Reserve's interest rate decision next week.

Read more
13 Sep 2023 08:57

LONDON MARKET OPEN: Stocks mixed ahead of key US inflation reading

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of a key US inflation reading, which might impact future interest rate decisions.

Read more
13 Sep 2023 08:48

TOP NEWS: Aviva gets GBP800 million from Singapore Life exit

(Alliance News) - Aviva PLC on Wednesday said it has agreed to sell its quarter ownership of Singapore Life Holdings Pte Ltd to fellow shareholder Sumitomo Life Insurance Co for a total of SGD1.4 billion, about GBP800 million.

Read more
13 Sep 2023 07:01

Aviva sells stake in Singlife, debt instruments to Sumitomo for £0.8bn

(Sharecast News) - UK insurer Aviva on Wednesday said it had agreed to sell its 25.9% stake in Singapore Life Holdings (Singlife), together with two debt instruments, to Sumitomo Life for £800m in cash.

Read more
11 Sep 2023 09:33

LONDON BROKER RATINGS: RBC cuts Melrose Industries to 'sector perform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
7 Sep 2023 09:45

LONDON BROKER RATINGS: RBC ups ConvaTec; Peel Hunt cuts Harbour Energy

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
5 Sep 2023 14:02

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:58

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:38

CORRECTED (OFFICIAL)-Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 06:00

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
4 Sep 2023 16:27

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Novo says Wegovy launch in UK 'controlled and limited'

*

Read more
4 Sep 2023 11:05

British private insurer Aviva will not pay for Novo's weight-loss drug Wegovy

LONDON, Sept 4 (Reuters) - British private insurer Aviva has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the UK on Monday.

Read more
31 Aug 2023 17:02

Miners drag FTSE 100 lower to snap 6-day winning streak

Glencore among top losers on FTSE 100

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.